SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-032810
Filing Date
2024-08-16
Accepted
2024-08-16 16:05:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 90897
  Complete submission text file 0001493152-24-032810.txt   92516
Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 241216678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)